Ketamine + Cognitive Training for Suicidality in the Medical Setting

Brief Summary

This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat suicidality more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.

Intervention / Treatment

  • Drug: Intravenous Ketamine
  • Behavioral: Cognitive training
  • Behavioral: Sham Training

Condition or Disease

  • Suicide, Attempted

Phase

Study Design

Study type: Interventional
Status: Enrolling by invitation
Study results: No Results Available
Age: 18 Years to 65 Years   (Adult, Older Adult)
Enrollment: 80 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Dec 19, 2019
Primary Completion: Jan 23, 2020
Completion Date: Jan 24, 2020
Study First Posted: Nov 06, 2019
Results First Posted: Aug 31, 2020
Last Updated: Jan 18, 2020

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Eligibility Criteria

Sex: All
Minimum Age: 18
Maximum Age: 65

More Details

NCT Number: NCT04154150
Other IDs: STUDY19100041
Study URL: https://ClinicalTrials.gov/show/NCT04154150
Last updated: Jun 17, 2022